FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1925599086> ?p ?o ?g. }

• W1925599086 abstract "Background Osteoarthritis (OA) is a common joint disorder. In the knee, injections of corticosteroids into the joint (intraarticular (IA)) may relieve inflammation, and reduce pain and disability. Objectives To evaluate the efficacy and safety of IA corticosteroids in treatment of OA of the knee. Search methods We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (Issue 2, 2003), MEDLINE (to January (week 1) 2006 for update), EMBASE, PREMEDLINE (all to July 2003), and Current Contents (Sept 2000). Specialised journals, trial reference lists and review articles were handsearched. Selection criteria Randomised controlled trials of IA corticosteroids for patients with OA of the knee: single/double blind, placebo‐based/comparative studies, reporting at least one core OMERACT III outcome measure. Data collection and analysis Methodological quality of trials was assessed, and data were extracted in duplicate. Fixed effect and random effects models, giving weighted mean differences (WMD), were used for continuous variables. Dichotomous outcomes were analysed by relative risk (RR). Main results Twenty‐eight trials (1973 participants) comparing IA corticosteroid against placebo, against IA hyaluronan/hylan (HA products), against joint lavage, and against other IA corticosteroids, were included. IA corticosteroid was more effective than IA placebo for pain reduction (WMD ‐21.91; 95% confidence interval (CI) ‐29.93 to ‐13.89) and patient global assessment (the RR was 1.44 (95% CI 1.13 to 1.82)) at one week post injection with an NNT of 3 to 4 for both, based on n=185 for pain on 100 mm visual analogue scale (VAS) and n=158 for patient global assessment. Data on function were sparse at one week post injection and neither statistically significant nor clinically important differences were detected. There was evidence of pain reduction between two weeks (the RR was 1.81 (95% CI 1.09 to 3.00)) to three weeks (the RR was 3.11 (95% CI 1.61 to 6.01), but a lack of evidence for efficacy in functional improvement. At four to 24 weeks post injection, there was lack of evidence of effect on pain and function (small studies showed benefits which did not reach statistical or clinical importance, i.e. less than 20% risk difference). For patient global, there were three studies which consistently showed lack of effect longer than one week post injection. However, all were fairly small sample sizes (less than 50 patients per group). This was supported by another study which did not find statistically significant differences, at any time point, on a continuous measure of patient global assessment (100 mm VAS). In comparisons of corticosteroids and HA products, no statistically significant differences were in general detected at one to four weeks post injection. Between five and 13 weeks post injection, HA products were more effective than corticosteroids for one or more of the following variables: WOMAC OA Index, Lequesne Index, pain, range of motion (flexion), and number of responders. One study showed a difference in function between 14 to 26 weeks, but no differences in efficacy were detected at 45 to 52 weeks. In general, the onset of effect was similar with IA corticosteroids, but was less durable than with HA products. Comparisons of IA corticosteroids showed triamcinolone hexacetonide was superior to betamethasone for number of patients reporting pain reduction up to four weeks post injection (the RR was 2.00 (95% CI 1.10 to 3.63). Comparisons between IA corticosteroid and joint lavage showed no differences in any of the efficacy or safety outcome measures. Authors' conclusions The short‐term benefit of IA corticosteroids in treatment of knee OA is well established, and few side effects have been reported. Longer term benefits have not been confirmed based on the RevMan analysis. The response to HA products appears more durable. In this review, some discrepancies were observed between the RevMan 4.2 analysis and the original publication. These are likely the result of using secondary rather than primary data and the statistical methods available in RevMan 4.2. Future trials should have standardised outcome measures and assessment times, run longer, investigate different patient subgroups, and clinical predictors of response (those associated with inflammation and structural damage)." @default.
• W1925599086 created "2016-06-24" @default.
• W1925599086 creator A5031606612 @default.
• W1925599086 creator A5035644440 @default.
• W1925599086 creator A5036240375 @default.
• W1925599086 creator A5059733353 @default.
• W1925599086 creator A5068749829 @default.
• W1925599086 creator A5083388718 @default.
• W1925599086 date "2006-04-19" @default.
• W1925599086 modified "2023-10-13" @default.
• W1925599086 title "Intraarticular corticosteroid for treatment of osteoarthritis of the knee" @default.
• W1925599086 cites W1531651629 @default.
• W1925599086 cites W1965931799 @default.
• W1925599086 cites W1968033708 @default.
• W1925599086 cites W1968613325 @default.
• W1925599086 cites W1980697952 @default.
• W1925599086 cites W1984338080 @default.
• W1925599086 cites W1985976081 @default.
• W1925599086 cites W1986215651 @default.
• W1925599086 cites W1988323348 @default.
• W1925599086 cites W1988861536 @default.
• W1925599086 cites W1989476125 @default.
• W1925599086 cites W1990692609 @default.
• W1925599086 cites W2011504006 @default.
• W1925599086 cites W2017638669 @default.
• W1925599086 cites W2024889251 @default.
• W1925599086 cites W2027234518 @default.
• W1925599086 cites W2028772712 @default.
• W1925599086 cites W2030825356 @default.
• W1925599086 cites W2030838816 @default.
• W1925599086 cites W2045172616 @default.
• W1925599086 cites W2047985623 @default.
• W1925599086 cites W2049245713 @default.
• W1925599086 cites W2049513502 @default.
• W1925599086 cites W2057627035 @default.
• W1925599086 cites W2058147305 @default.
• W1925599086 cites W2064806888 @default.
• W1925599086 cites W2072628398 @default.
• W1925599086 cites W2087329901 @default.
• W1925599086 cites W2088825980 @default.
• W1925599086 cites W2096059782 @default.
• W1925599086 cites W2097619910 @default.
• W1925599086 cites W2099901505 @default.
• W1925599086 cites W2102292476 @default.
• W1925599086 cites W2102308673 @default.
• W1925599086 cites W2105217120 @default.
• W1925599086 cites W2106316114 @default.
• W1925599086 cites W2111664065 @default.
• W1925599086 cites W2113317913 @default.
• W1925599086 cites W2113661374 @default.
• W1925599086 cites W2116256535 @default.
• W1925599086 cites W2116959483 @default.
• W1925599086 cites W2129802102 @default.
• W1925599086 cites W2146572310 @default.
• W1925599086 cites W2148360183 @default.
• W1925599086 cites W2150623435 @default.
• W1925599086 cites W2150908378 @default.
• W1925599086 cites W2163683772 @default.
• W1925599086 cites W2169870007 @default.
• W1925599086 cites W2234326766 @default.
• W1925599086 cites W2274600689 @default.
• W1925599086 cites W2286250356 @default.
• W1925599086 cites W2292904343 @default.
• W1925599086 cites W2339163240 @default.
• W1925599086 cites W2462258241 @default.
• W1925599086 cites W2610860323 @default.
• W1925599086 cites W2984943016 @default.
• W1925599086 cites W325876603 @default.
• W1925599086 cites W4214559180 @default.
• W1925599086 cites W4238482724 @default.
• W1925599086 cites W4245703231 @default.
• W1925599086 cites W69686190 @default.
• W1925599086 doi "https://doi.org/10.1002/14651858.cd005328.pub2" @default.
• W1925599086 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16625636" @default.
• W1925599086 hasPublicationYear "2006" @default.
• W1925599086 type Work @default.
• W1925599086 sameAs 1925599086 @default.
• W1925599086 citedByCount "464" @default.
• W1925599086 countsByYear W19255990862012 @default.
• W1925599086 countsByYear W19255990862013 @default.
• W1925599086 countsByYear W19255990862014 @default.
• W1925599086 countsByYear W19255990862015 @default.
• W1925599086 countsByYear W19255990862016 @default.
• W1925599086 countsByYear W19255990862017 @default.
• W1925599086 countsByYear W19255990862018 @default.
• W1925599086 countsByYear W19255990862019 @default.
• W1925599086 countsByYear W19255990862020 @default.
• W1925599086 countsByYear W19255990862021 @default.
• W1925599086 countsByYear W19255990862022 @default.
• W1925599086 countsByYear W19255990862023 @default.
• W1925599086 crossrefType "reference-entry" @default.
• W1925599086 hasAuthorship W1925599086A5031606612 @default.
• W1925599086 hasAuthorship W1925599086A5035644440 @default.
• W1925599086 hasAuthorship W1925599086A5036240375 @default.
• W1925599086 hasAuthorship W1925599086A5059733353 @default.
• W1925599086 hasAuthorship W1925599086A5068749829 @default.
• W1925599086 hasAuthorship W1925599086A5083388718 @default.
• W1925599086 hasConcept C126322002 @default.
• W1925599086 hasConcept C14184104 @default.
• W1925599086 hasConcept C142724271 @default.

• next